Brown Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Sell
2,070
-3
-0.1% -$645 0.18% 111
2026
Q1
$451K Sell
2,073
-25
-1% -$5.55K 0.17% 117
2025
Q4
$479K Sell
2,098
-182
-8% -$41.5K 0.18% 111
2025
Q3
$528K Buy
2,280
+34
+2% +$6.92K 0.2% 99
2025
Q2
$417K Sell
2,246
-20
-0.9% -$3.72K 0.16% 123
2025
Q1
$475K Sell
2,266
-385
-15% -$74.8K 0.2% 103
2024
Q4
$471K Buy
2,651
+177
+7% +$32.5K 0.19% 98
2024
Q3
$489K Sell
2,474
-1,748
-41% -$326K 0.2% 103
2024
Q2
$724K Buy
+4,222
New +$699K 0.32% 97

Other funds holding ABBV

Brown Financial Advisors's ABBV Position: Q2 2026 in Review

Brown Financial Advisors reduced its AbbVie (ABBV) stake by 0.14% in Q2 2026, selling an estimated $645 and leaving 2,070 shares worth $521K. The position accounts for 0.18% of the portfolio, ranked #111.

Brown Financial Advisors first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $724K in Q2 2024. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brown Financial Advisors held 2,070 shares of AbbVie worth $521K as of Q2 2026.
  • Brown Financial Advisors sold 3 AbbVie shares in Q2 2026, an estimated $645.
  • AbbVie made up 0.18% of Brown Financial Advisors's portfolio in Q2 2026, its #111 holding.
  • Brown Financial Advisors first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • Brown Financial Advisors's AbbVie position peaked at $724K in Q2 2024.
  • 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brown Financial Advisors's 13F filing for Q2 2026, filed 26 Aug 2026.